Talon Private Wealth LLC boosted its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 15,907.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,241 shares of the company's stock after buying an additional 2,227 shares during the period. Talon Private Wealth LLC's holdings in Procter & Gamble were worth $382,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Nuveen LLC bought a new stake in Procter & Gamble in the first quarter worth $1,954,941,000. GAMMA Investing LLC grew its holdings in Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after purchasing an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Invesco Ltd. lifted its position in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Procter & Gamble by 15.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after purchasing an additional 2,224,912 shares during the period. 65.77% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on PG shares. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the stock a "buy" rating in a research note on Wednesday, July 30th. BNP Paribas reissued an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Wells Fargo & Company decreased their price objective on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Finally, Evercore ISI reiterated an "in-line" rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $175.12.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, insider Marc S. Pritchard sold 9,849 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the sale, the insider directly owned 182,422 shares of the company's stock, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the sale, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $160.08 on Monday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $374.65 billion, a P/E ratio of 24.59, a P/E/G ratio of 4.22 and a beta of 0.36. The firm's 50 day moving average is $156.41 and its two-hundred day moving average is $162.21. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same period last year, the firm posted $1.40 EPS. Procter & Gamble's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio is 64.98%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report